Chemours (CC) PT Lowered to $22 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq retreat from record highs as yields and oil climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $13.83 -1.78%
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 66
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 66
Join SI Premium – FREE
Barclays analyst Michael Leithead lowered the price target on Chemours (NYSE: CC) to $22.00 (from $30.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Chemours (CC) PT Lowered to $16 at UBS
- Mobileye N.V (MBLY) PT Lowered to $7.50 at UBS
- Charles Schwab Corp. (SCHW) PT Lowered to $113 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
